共 41 条
- [31] Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factorsJournal of Cancer Research and Clinical Oncology, 2015, 141 : 109 - 118Xiaodong ZhuXiaoying ZhaoWei PengSi SunJun CaoDongmei JiXin LiuChenchen WangMingzu HuangHui YuWeijian GuoJin LiJiliang Yin
- [32] Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factorsJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (01) : 109 - 118Zhu, XiaodongZhao, XiaoyingPeng, WeiSun, SiCao, JunJi, DongmeiLiu, XinWang, ChenchenHuang, MingzuYu, HuiGuo, WeijianLi, JinYin, Jiliang
- [33] CONTINUOUS INFUSION 5-FLUOROURACIL WITH BOLUS ADRIAMYCIN AND MITOMYCIN AND LOW-DOSE CISPLATIN (FAMP) IN THE TREATMENT OF METASTATIC GASTRIC-CARCINOMA - AN EVALUATION OF EFFICACY AND TOXICITYCANCER INVESTIGATION, 1991, 9 (01) : 49 - 51RASCHKO, JWJOHNSON, EAUENO, WWOOLLEY, PVTREAT, J
- [34] Continuous interleukin-2 infusion combined with cyclophosphamide-based combination chemotherapy in the treatment of hemato-oncological malignancies - Results of a phase I-II studyACTA HAEMATOLOGICA, 1998, 100 (02) : 63 - 68Nagler, AAckerstein, ABen-Shahar, MOr, RNaparstek, EBen-Yosef, RSlavin, S
- [35] Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): Low palliative benefit and high treatment-related toxicityJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (05) : 316 - 320Yen, CCTung, SLHsieh, RKChiou, TJLiu, JHWang, WSChen, PM
- [36] Efficacy and safety of henagliflozin combined with continuous subcutaneous insulin infusion in the treatment of Chinese inpatients with type 2 diabetes mellitus based on a continuous glucose monitoring system: protocol of a multicentre, open-label, inpatient, randomised, controlled trialBMJ OPEN, 2024, 14 (10):Wu, YinglingHuang, ZhenxingQin, Yingfen
- [37] Diabetes remission in newly diagnosed type 2 diabetes mellitus through short-term continuous subcutaneous insulin infusion intensive therapy combined with low-carbohydrate diet treatmentJOURNAL OF DIABETES INVESTIGATION, 2024,Huang, XuemeiJiang, JiajinLiu, LiLin, YuanyuanZhang, FengLing, XiaoshanWei, HaitaoHuang, GuangjingYe, JinqunHuang, CenHuang, JianliTao, WenfuZou, Xinyu
- [38] HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancerRADIOTHERAPY AND ONCOLOGY, 2019, 131 : 27 - 34Zhai, YiruiMa, HonglianHui, ZhouguangZhao, LujunLi, DongmingLiang, JunWang, XiaozhenXu, LimingChen, BoTang, YuWu, RunyeXu, YujinPang, QingsongChen, MingWang, Luhua
- [39] Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?ANTIBIOTICS-BASEL, 2025, 14 (02):Cojutti, Pier GiorgioTedeschi, SaraZamparini, EleonoraFornaro, GiacomoZagarrigo, ManuelDe Paolis, MassimilianoViale, PierluigiPea, Federico
- [40] Continuous intravenous infusion of recombinant human endostatin combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer (HELPER): a phase 2, multicentre studyLANCET ONCOLOGY, 2017, 18 : S11 - S11Zhai, YiruiMa, HonglianHui, ZhouguangZhao, LujunLi, DongmingLiang, JunWang, XiaozhenXu, LimingChen, BoTang, YuWu, RunyeXu, YujinChen, MingWang, Luhua